Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung [Phase 2]
A Phase 2 trial evaluating durvalumab with consolidation SBRT after chemoradiation for locally advanced stage III non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours [Phase 1]
Clinical trial update describes a Phase 1 dose-escalation study of [225Ac]-FPI-2068 in adults with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study of TAS3351 in NSCLC Patients With EGFRmt [Phase 1]
Phase 1 study of TAS3351 in EGFR-mutant non-small cell lung cancer was terminated, with results posted on 2026-04-02.
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: A Study to Investigate Safety, Tolerability, PK and Anti-tumor Activity of TRX-221 in EGFRm NSCLC Patients [Phase 1, Phase 2]
A Phase 1/2 trial of TRX-221 in EGFR-mutant non-small cell lung cancer has been terminated; the update covers safety, tolerability, pharmaco…
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer [EARLY_Phase 1]
This EARLY Phase 1 clinical trial evaluates stereotactic body radiation therapy followed by surgery for patients with stage I to IIIA non-sm…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab) [Phase 3]
This Phase 3 clinical trial update reports pharmacokinetic similarity between ABP-234, a pembrolizumab biosimilar, and Keytruda (pembrolizum…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Genomically Guided Radiation Dose Personalization in Locally Advanced NSCLC [EARLY_Phase 1]
Early-phase trial results explore genomically guided radiation dose personalization for locally advanced non-small cell lung cancer, aiming …
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor [Phase 3]
Phase 3 trial update indicates OSE2101, a therapeutic cancer vaccine, is being studied in non-small cell lung cancer patients with secondary…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 trial update reports on the safety and efficacy of a neoantigen-based personalized immunotherapy used as consolidation therapy …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Safety and Efficacy of Xalkori ROS1
This clinical trial update summarizes safety and efficacy findings for crizotinib (Xalkori) in patients with ROS1-rearranged non-small cell …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC [Phase 1]
A Phase 1 trial is evaluating a KRAS-targeted vaccine in combination with nivolumab and ipilimumab for non-small cell lung cancer. The study…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Expanded Access to Provide Sevabertinib (BAY 2927088) for the Treatment of Locally Advanced or Metastatic NSCLC With HER2 Mutation
Bayer is offering expanded access to Sevabertinib (BAY 2927088) for patients with locally advanced or metastatic non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Capmatinib in Chinese Adult Patients With Advanced Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation [Phase 2]
A Phase 2 study of capmatinib in Chinese adults with advanced MET exon 14 skipping mutation–positive non-small cell lung cancer has complete…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) [Phase 2]
Phase 2 trial KRYSTAL 21 is evaluating two adagrasib dosing regimens in non-small cell lung cancer with KRAS G12C mutation; the study is act…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial evaluating Nanrilkefusp alfa alone and with pembrolizumab in adults with advanced or metastatic solid tumors; the study (NCT04…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery [Phase 1]
A Phase 1 trial update describes light dosimetry for photodynamic therapy using porfimer sodium in participants with malignant mesothelioma …
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
An ongoing clinical trial is evaluating osimertinib in combination with intracranial stereotactic radiotherapy for EGFR-mutant non-small cel…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy [Phase 2]
A Phase 2 study evaluated thoracic radiotherapy plus durvalumab in elderly and/or frail patients with non-small cell lung cancer stage III w…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial is evaluating a KRAS-specific autologous TCR-T cell therapy for KRAS-mutant advanced solid tumors, including colore…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial of IMU-201 (PD1-Vaxx) in adults with non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating adding berzosertib to standard carboplatin/gemcitabine and to pembrolizumab for patients with advan…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy [Phase 1]
This is a Phase I trial evaluating atezolizumab with interleukin-12 gene therapy in metastatic non-small cell lung cancer that progressed af…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer [Phase 1]
Phase 1 study evaluating the efficacy and safety of Cofetuzumab Pelidotin in PTK7-expressing, recurrent non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Phase III Study of AK112 for NSCLC Patients [Phase 3]
This document provides an update on a Phase III trial of AK112 for non-small cell lung cancer. The study is currently active but not recruit…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Family-Supported Palliative Care in Advanced Lung Cancer [NA]
This clinical trial evaluated family-supported palliative care in advanced lung cancer, including non-small cell lung cancer, and has comple…